CR20130358A - Derivados de piperidina puenteada - Google Patents

Derivados de piperidina puenteada

Info

Publication number
CR20130358A
CR20130358A CR20130358A CR20130358A CR20130358A CR 20130358 A CR20130358 A CR 20130358A CR 20130358 A CR20130358 A CR 20130358A CR 20130358 A CR20130358 A CR 20130358A CR 20130358 A CR20130358 A CR 20130358A
Authority
CR
Costa Rica
Prior art keywords
amyloid
disease
derivatives
brain
bridged piperidine
Prior art date
Application number
CR20130358A
Other languages
English (en)
Inventor
Karlheinz Baumann
Luke Green
Anja Limberg
Thomas Luebbers
Andrew Thomas
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of CR20130358A publication Critical patent/CR20130358A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

LOS COMPUESTOS PRESENTES DE LA FÓRMULA I SON MODULARES DE BETA-AMILOIDE Y POR ELLO PUEDEN SER ÚTILES PARA EL TRATAMIENTO OP PREVENCIÓN DE UNA ENFERMEDAD ASOCIADA CON LA DEPOSICIÓN DE B-AMILOIDE EN EL CEREBRO, EN PARTICULAR LA ENFERMEDAD DE ALZHEIMER Y OTRAS ENFERMEDADES, COMO SON LA ANTIGIOPATÍA CEREBRAL AMILOIDE, LA HEMORRAGIA CEREBRAL HEREDITARIA CON AMILOIDOSIS DE TIPO DUTCH (HCHWA-D), LA DEMENCIA MULTIINFARTO, LA DEMENCIA PUGILÍSTICA Y EL SÍNDROME DE DOWN.-
CR20130358A 2011-03-02 2013-07-23 Derivados de piperidina puenteada CR20130358A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11156587 2011-03-02

Publications (1)

Publication Number Publication Date
CR20130358A true CR20130358A (es) 2013-10-03

Family

ID=45757448

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20130358A CR20130358A (es) 2011-03-02 2013-07-23 Derivados de piperidina puenteada

Country Status (21)

Country Link
US (1) US8703763B2 (es)
EP (1) EP2681214B1 (es)
JP (1) JP5753591B2 (es)
KR (1) KR101550122B1 (es)
CN (1) CN103403003B (es)
BR (1) BR112013021924A2 (es)
CA (1) CA2824239A1 (es)
CL (1) CL2013002474A1 (es)
CO (1) CO6761320A2 (es)
CR (1) CR20130358A (es)
EA (1) EA025035B1 (es)
EC (1) ECSP13012858A (es)
IL (1) IL227251A (es)
MA (1) MA34964B1 (es)
MX (1) MX2013009031A (es)
MY (1) MY167264A (es)
PE (1) PE20140250A1 (es)
SG (1) SG193239A1 (es)
UA (1) UA110368C2 (es)
WO (1) WO2012116965A1 (es)
ZA (1) ZA201305322B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5321839B2 (ja) * 2007-04-25 2013-10-23 日産化学工業株式会社 ポリイミド前駆体及びポリイミド並びに画像形成下層膜塗布液
US11090297B2 (en) 2013-06-21 2021-08-17 Prilenia Neurotherapeutics Ltd. Pridopidine for treating huntington's disease
EP3347363B1 (en) * 2015-09-09 2020-01-01 H. Hoffnabb-La Roche Ag N-(3-azabicyclo[3.2.1]octan-8-yl)-8-(4-phenyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[l,5-a]pyridin-2-amine derivatives as gamma-secretase modulators for treating alzheimer's disease
MX2018005890A (es) 2015-11-12 2018-08-15 Hoffmann La Roche Composiciones para tratar atrofia muscular espinal.
CN108137579B (zh) * 2015-12-10 2022-01-07 豪夫迈·罗氏有限公司 桥连哌啶衍生物
ES2879995T3 (es) 2015-12-10 2021-11-23 Ptc Therapeutics Inc Métodos para el tratamiento de la enfermedad de Huntington
EP3475279B1 (en) * 2016-06-27 2021-07-14 F. Hoffmann-La Roche AG Triazolopyridines as gamma-secretase modulators
EP3484884B1 (en) 2016-07-14 2021-01-27 Hoffmann-La Roche AG Fused pyrimidine derivatives
JP6912574B2 (ja) 2016-08-24 2021-08-04 プリレニア ニューロセラピューティクス リミテッド 機能低下を治療するためのプリドピジンの使用
AR109829A1 (es) * 2016-09-29 2019-01-30 Hoffmann La Roche Derivados de piperidina puenteados
CN109476670B (zh) * 2016-10-04 2022-06-28 豪夫迈·罗氏有限公司 二环杂芳基衍生物
JP7111704B2 (ja) * 2016-11-01 2022-08-02 エフ．ホフマン－ラ ロシュ アーゲー 二環式ヘテロアリール誘導体
WO2018087018A1 (en) 2016-11-08 2018-05-17 F. Hoffmann-La Roche Ag Phenoxytriazoles
JP6904612B2 (ja) 2016-12-16 2021-07-21 パイプライン セラピューティクス， インコーポレイテッド 蝸牛シナプス障害を処置する方法
EA201992878A1 (ru) 2017-06-05 2020-05-08 ПиТиСи ТЕРАПЬЮТИКС, ИНК. Соединения для лечения болезни хантингтона
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
BR112019027717A2 (pt) 2017-06-28 2020-07-28 Ptc Therapeutics, Inc. métodos para tratar a doença de huntington
WO2019121596A1 (en) * 2017-12-19 2019-06-27 Boehringer Ingelheim International Gmbh Triazolo pyridines as modulators of gamma-secretase
EP3743428B1 (en) 2018-01-22 2022-01-19 F. Hoffmann-La Roche AG Triazolo-azepine derivatives
CN112135815A (zh) 2018-03-27 2020-12-25 Ptc医疗公司 用于治疗亨廷顿氏病的化合物
EP3814360A1 (en) 2018-06-27 2021-05-05 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
AU2019294478B2 (en) 2018-06-27 2023-03-23 Ptc Therapeutics, Inc. Heterocyclic and heteroaryl compounds for treating Huntington's disease
PT3846903T (pt) * 2018-09-03 2023-12-14 Hoffmann La Roche Derivados heteroarílicos bicíclicos
US20220056036A1 (en) * 2018-12-13 2022-02-24 Hoffmann-La Roche Inc. 7-phenoxy-n-(3-azabicyclo[3.2.1]octan-8-yl)-6,7-dihydro-5h-pyrrolo[1,2-b][1,2,4]triazol-2-amine derivatives and related compounds as gamma-secretase modulators for the treatment of alzheimer's disease
CN113372364A (zh) * 2020-03-10 2021-09-10 明慧医药（上海）有限公司 一类jak激酶抑制剂及其制备和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432985B2 (en) * 2000-04-25 2002-08-13 Hoffmann-La Roche Inc. Neuroprotective substituted piperidine compounds with activity as NMDA NR2B subtype selective antagonists
US7037902B2 (en) 2002-07-03 2006-05-02 Receptron, Inc. Affinity small molecules for the EPO receptor
HU227684B1 (en) 2003-08-29 2011-11-28 Sanofi Aventis Adamantane and azabicyclo-octane and nonane derivatives and their use as dpp-iv inhibitors
EA014057B1 (ru) * 2005-10-06 2010-08-30 Ниппон Сода Ко., Лтд. Поперечно связанные соединения циклических аминов и средства для борьбы с вредителями
CA2713716A1 (en) 2008-02-22 2009-08-27 F. Hoffmann-La Roche Ag Modulators for amyloid beta
US20110190269A1 (en) 2010-02-01 2011-08-04 Karlheinz Baumann Gamma secretase modulators
US8486967B2 (en) 2010-02-17 2013-07-16 Hoffmann-La Roche Inc. Heteroaryl substituted piperidines

Also Published As

Publication number Publication date
IL227251A (en) 2016-09-29
US8703763B2 (en) 2014-04-22
UA110368C2 (en) 2015-12-25
SG193239A1 (en) 2013-10-30
JP5753591B2 (ja) 2015-07-22
US20120225884A1 (en) 2012-09-06
CN103403003A (zh) 2013-11-20
EP2681214A1 (en) 2014-01-08
AU2012222426A1 (en) 2013-07-11
MY167264A (en) 2018-08-14
PE20140250A1 (es) 2014-03-12
BR112013021924A2 (pt) 2020-10-20
KR101550122B1 (ko) 2015-09-03
CN103403003B (zh) 2016-09-14
ECSP13012858A (es) 2013-10-31
CO6761320A2 (es) 2013-09-30
KR20130140142A (ko) 2013-12-23
EA201391209A1 (ru) 2013-12-30
CL2013002474A1 (es) 2014-05-30
EP2681214B1 (en) 2017-03-22
IL227251A0 (en) 2013-09-30
MA34964B1 (fr) 2014-03-01
CA2824239A1 (en) 2012-09-07
MX2013009031A (es) 2013-09-02
NZ612525A (en) 2015-08-28
ZA201305322B (en) 2014-04-30
EA025035B1 (ru) 2016-11-30
WO2012116965A1 (en) 2012-09-07
JP2014506903A (ja) 2014-03-20

Similar Documents

Publication Publication Date Title
CR20130358A (es) Derivados de piperidina puenteada
ECSP22091792A (es) Compuestos tricíclicos sustituidos como inhibidores del receptor del factor de crecimiento de fibroplastos
CR20140578A (es) Benzamidas n-sustituidas y su uso en el tratamiento del dolor
NI200900177A (es) 3 - imidazolil - indoles para el tratamiento de enfermedades proliferativas.
CO6650361A2 (es) Derivados de indolizina, su procedimiento de preparacion y su aplicacion en terapeutica
CR20140301A (es) Derivados de betulina
CR20150078A (es) Análogos de piridazina 1,4-disustituida y métodos para el tratamiento de condiciones relacionadas con la deficiencia de smn
AR094313A1 (es) Inhibidores de fosfatidilinositol 3-quinasa
PE20151023A1 (es) Triazolopirazinas
NI201200190A (es) Composiciones y métodos para modular la vía de señalización de wnt
AR080177A1 (es) Derivados de piperidina, un procedimiento para su preparacion, y su uso en medicamentos para el tratamiento de enfermedades mentales asociadas a la deposicion del beta-amiloide en el cerebro.
MX2010008700A (es) Moduladores de beta-amiloide.
CO6620055A2 (es) Ciertas amino-pirimidinas, composiciones de las mismas y métodos para el uso de los mismos
CO6650360A2 (es) Derivados de imidazopiridina, su procedimiento de preparació;n y su aplicación en terapéutica
PE20141972A1 (es) Inhibidores de la beta-secretasa
CU20150062A7 (es) Lactamas n-(heteroarilo sustituido) fusionadas utiles en el tratamiento del crecimiento celular anormal
CU20120099A7 (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
ECSP12011945A (es) Espiroindolinona-pirrolidinas
UY33564A (es) 2-arilamino-5-aminocarbonil-benzimidazoles novedosos
CO6460766A2 (es) Compuestos de haloalquil heteroaril benzamida
NI200900148A (es) COMPUESTOS TRICÍCLICOS, COMPOSICIONES, Y PROCEDIMIENTOS. Caso: PC33536A
CO6670575A2 (es) Aminopirazoloqinazolinas sustituidas, útiles en el tratamiento de enfermedades proliferativas y composiciones farmaceúticas que las continen
CO6660435A2 (es) Una forma cristalina de clorhidrato de (r) -7- cloro-n- (quinuclidin -3-il)benzo[b] tiofeno-2- carboxamida monohodratado
AR097435A1 (es) 6-alquinilpiridinas
CR11759A (es) Nueva clase de espiro piperidinas para el tratamiento de enfermedades neurodegenerativas